Mayo Clinic Review: Can CBD Help Treat Heart Disease?
CBD shows promising anti-inflammatory and cardioprotective properties in preclinical studies, but clinical evidence for cardiovascular applications remains limited.
Quick Facts
What This Study Found
CBD demonstrates potential anti-inflammatory, antioxidant, and vasodilatory properties relevant to pericarditis, ischemic heart disease, heart failure, and cardiac arrhythmias, with preliminary trials showing promise for recurrent pericarditis.
Key Numbers
Review covered evidence on CBD's role across multiple cardiovascular conditions including ischemia-reperfusion injury, myocardial fibrosis, and cardiac arrhythmias.
How They Did This
Narrative review from Mayo Clinic researchers integrating preclinical and emerging clinical evidence on CBD in cardiovascular disease management.
Why This Research Matters
Heart disease remains the leading cause of death globally, and CBD's unique anti-inflammatory profile — without immunosuppressive effects — could fill a gap in treating inflammatory cardiac conditions.
The Bigger Picture
If clinical trials confirm preclinical findings, CBD could become a nonimmunosuppressive therapy option for inflammatory heart conditions — a category with few current alternatives.
What This Study Doesn't Tell Us
Most evidence comes from preclinical models; limited human clinical trials, dosing inconsistencies, and regulatory challenges hinder translation to clinical practice.
Questions This Raises
- ?What are the optimal CBD doses for cardiovascular benefit?
- ?How do CBD drug interactions affect cardiac medications?
- ?Can large-scale trials validate the preclinical cardioprotective signals?
Trust & Context
- Key Stat:
- Evidence Grade:
- Comprehensive narrative review from a leading medical institution, but limited by the scarcity of human clinical trials and dosing standardization.
- Study Age:
- Published in 2026 in Mayo Clinic Proceedings, reflecting cutting-edge cardiovascular cannabinoid research.
- Original Title:
- Cannabidiol in Cardiovascular Disease: A Review of Current Evidence and Future Directions.
- Published In:
- Mayo Clinic proceedings, 101(2), 297-309 (2026)
- Authors:
- Abdalla, Hesham M, Bacon, Adam, VanDolah, Hunter, Dreher, Luke, Pathangey, Girish, Abdelnabi, Mahmoud, Ibrahim, Ramzi, Pereyra, Milagros, Farina, Juan M, Luis, S Allen, Arsanjani, Reza, Ayoub, Chadi
- Database ID:
- RTHC-08059
Evidence Hierarchy
Summarizes existing research without a strict systematic method.
What do these levels mean? →Frequently Asked Questions
Can CBD treat heart disease?
Preclinical evidence shows CBD has anti-inflammatory and cardioprotective properties, but clinical trials in humans are still very limited. It should not replace standard cardiac medications.
What heart conditions might benefit from CBD?
Early research suggests possible benefits for recurrent pericarditis, myocarditis, ischemia-reperfusion injury, and cardiac arrhythmias, though more trials are needed.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-08059APA
Abdalla, Hesham M; Bacon, Adam; VanDolah, Hunter; Dreher, Luke; Pathangey, Girish; Abdelnabi, Mahmoud; Ibrahim, Ramzi; Pereyra, Milagros; Farina, Juan M; Luis, S Allen; Arsanjani, Reza; Ayoub, Chadi. (2026). Cannabidiol in Cardiovascular Disease: A Review of Current Evidence and Future Directions.. Mayo Clinic proceedings, 101(2), 297-309. https://doi.org/10.1016/j.mayocp.2025.10.009
MLA
Abdalla, Hesham M, et al. "Cannabidiol in Cardiovascular Disease: A Review of Current Evidence and Future Directions.." Mayo Clinic proceedings, 2026. https://doi.org/10.1016/j.mayocp.2025.10.009
RethinkTHC
RethinkTHC Research Database. "Cannabidiol in Cardiovascular Disease: A Review of Current E..." RTHC-08059. Retrieved from https://rethinkthc.com/research/abdalla-2026-cannabidiol-in-cardiovascular-disease
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.